TET2 orchestrates YAP signaling to potentiate targetable vulnerability in hepatocellular carcinoma
Abstract Hepatocellular carcinoma (HCC) is a leading cause of global cancer-associated mortality. Although various therapies have substantially ameliorated clinical outcome, patients invariably suffer from cancer relapse, highlighting the need for more optimized therapeutic strategies. Here, we repo...
Saved in:
| Main Authors: | Jing He, Mingen Lin, Fei Teng, Xue Sun, Ziyin Tian, Jiaxi Li, Yan Ma, Yue Dai, Yi Gao, Hongchen Li, Tongguan Tian, Kai Xu, Xinxing Li, Lei Lv, Yanping Xu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-06-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07745-3 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
HNF4α-TET2-FBP1 axis contributes to gluconeogenesis and type 2 diabetes
by: Hongchen Li, et al.
Published: (2025-06-01) -
Correction: Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma
by: Yue Dai, et al.
Published: (2025-05-01) -
Dimethyl fumarate promotes the degradation of HNF1B and suppresses the progression of clear cell renal cell carcinoma
by: Yue Dai, et al.
Published: (2025-02-01) -
p53 inhibits OTUD5 transcription to promote GPX4 degradation and induce ferroptosis in gastric cancer
by: Junjing Zhang, et al.
Published: (2025-03-01) -
Expression and Clinical Significance of YAP, TAZ, and AREG in Hepatocellular Carcinoma
by: Su-xia Han, et al.
Published: (2014-01-01)